Cleared Special

K231841 - PathLoc SI Joint Fusion System

K231841 is the FDA 510(k) clearance for PathLoc SI Joint Fusion System by L & K Biomed Co., Ltd.. It is a Class 2 Orthopedic device (product code OUR) cleared through the Special 510(k) pathway after a 22-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
22d
Days
Class 2
Risk

K231841 is an FDA 510(k) clearance for the PathLoc SI Joint Fusion System. Classified as Sacroiliac Joint Fixation (product code OUR), Class II - Special Controls.

Submitted by L & K Biomed Co., Ltd. (Yongin-Si, KR). The FDA issued a Cleared decision on July 14, 2023 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3040 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all L & K Biomed Co., Ltd. devices

Submission Details

510(k) Number K231841 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 22, 2023
Decision Date July 14, 2023
Days to Decision 22 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
100d faster than avg
Panel avg: 122d · This submission: 22d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code OUR Sacroiliac Joint Fixation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3040
Definition Sacroiliac Joint Fusion
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - OUR Sacroiliac Joint Fixation

All 103
Devices cleared under the same product code (OUR) and FDA review panel - the closest regulatory comparables to K231841.
Xenix Medical Sacroiliac Fixation System
K231829 · Ht Medical D.B.A. Xenix Medical · Aug 2023
TiLink-L Joint Fusion System
K231831 · Surgentec · Aug 2023
SI-Cure Sacroiliac Joint Fusion System
K231951 · Alevio, LLC · Jul 2023
iFuse TORQ® Implant System
K231689 · SI-BONE, Inc. · Jun 2023
TiLink-L SI Joint Fusion System
K230446 · SurGenTec, LLC · Jun 2023
Kisar Stratford SI Screw System
K220274 · Anjali Investments L.L.C · Apr 2023